NAGE

Niagen Bioscience

59 hedge funds and large institutions have $18.1M invested in Niagen Bioscience in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

5% less capital invested

Capital invested by funds: $19.1M → $18.1M (-$974K)

Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$146K
Puts
$41K
Net Calls
Net Calls Change

Top Sellers

1 -$300K
2 -$230K
3 -$220K
4
Barclays
Barclays
United Kingdom
-$168K
5
BlackRock
BlackRock
New York
-$127K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.79M
2
$3.9M
3
$1.98M
4
$1.38M
5
$853K
6
$785K
7
$654K
8
$454K
9
$321K
10
$298K
11
$291K
12
$270K
13
$240K
14
$167K
15
$159K
16
$147K
17
$145K
18
$133K
19
$129K
20
$105K
21
$84.2K
22
$69.9K
23
$61K
24
$52.9K
25
$46.1K